ICD-10-CM Code T50.905
Adverse effect of unspecified drugs, medicaments and biological substances

NON-BILLABLE

Non-Billable Code

Non-Billable means the code is not sufficient justification for admission to an acute care hospital when used a principal diagnosis. Use a child code to capture more detail.

7th Character Required

Code requires 7th Character Extension identifier. This 7th Character usually captures Episode of Care information, such as "Initial Encounter," "Subsquent Encounter," or "Sequela."

| ICD-10 from 2011 - 2016

ICD Code T50.905 is a non-billable code. To code a diagnosis of this type, you must use specify a 7th character that describes the diagnosis 'adverse effect of unsp drug/meds/biol subst' in more detail. The 7th characters that can be added, and the resulting billable codes, are as follows:

7th Digit	Billable Code	7th Digit Specifies
A	T50.905A	initial encounter
D	T50.905D	subsequent encounter
S	T50.905S	sequela

What is 7th Character Extension?

For codes less than 6 characters that require a 7th character a placeholder 'X' should be assigned for all characters less than 6. The 7th character must always be the 7th position of a code. E.g. The ICD-10-CM code T67.4 (Heat exhaustion due to salt depletion) requires an Episode of Care identifier. T67.4XXA Initial Encounter or T67.4XXD Subsequent Encounter. More Info

The ICD code T50 is used to code Drug overdose

The term drug overdose (or simply overdose or OD) describes the ingestion or application of a drug or other substance in quantities greater than are recommended or generally practiced. An overdose may result in a toxic state or death.

Specialty:	Toxicology
MeSH Codes:	D062787, D062787, D062787
ICD 9 Codes:	960, 970, 979

Activated carbon is a commonly used agent for decontamination of the gastrointestinal tract in overdoses.

Source: Wikipedia

Related Concepts SNOMET-CT

Infertility due to drug therapy (finding)
Dermatitis due to drug AND/OR medicine taken internally (disorder)
Drug-induced myasthenia (disorder)
Drug induced central sleep apnea (disorder)
Drug-induced megacolon (disorder)
Drug-induced cicatricial pemphigoid (disorder)
Gout secondary to drug (disorder)
Corneal rust ring (disorder)
Chronic follicular conjunctivitis due to drug (disorder)
Drug-induced bronchiolitis obliterans (disorder)
Drug-induced acute pulmonary edema (disorder)
Drug-induced orofacial dyskinesia (disorder)
Drug-induced androgenic alopecia (disorder)
Conjunctival adrenochrome deposits (disorder)
Drug-induced Stevens-Johnson syndrome (disorder)
Drug-induced systemic lupus erythematosus (disorder)
Drug-induced nephrogenic diabetes insipidus (disorder)
Iatrogenic hypopituitarism (disorder)
Salivary dysfunction caries secondary to medication (disorder)
Drug-induced pseudoporphyria (disorder)
Drug-induced dyskinesia, acute onset (disorder)
Subacute dyskinesia due to drug (disorder)
Drug-induced neutrophilia (disorder)
Drug-induced hypomagnesemia (disorder)
Myotonia due to drug (disorder)
Annular erythema due to drug (disorder)
Drug-induced hypersomnia (disorder)
Intrinsic staining of tooth - drug-induced (disorder)
Drug-induced chronic pancreatitis (disorder)
Medication bezoar (disorder)
Drug-induced flushing (disorder)
Drug-induced anetoderma (disorder)
Generalized eczema due to systemically administered drug (disorder)
Drug-induced dermatomyositis (disorder)
Drug-induced corneal epithlelial deposit (disorder)
Drug-induced akathisia (disorder)
Drug-induced erythroderma (disorder)
Acneiform drug eruption (disorder)
T-cell pseudolymphoma due to drug (disorder)
Drug-induced anaphylaxis (disorder)
Allergic reaction to systemically administered drug affecting oral mucosa (disorder)
Drug-induced gingival hyperplasia (disorder)